IQS, Inc., a provider of Enterprise Quality and Compliance Management Software, has been awarded a multi-year contract by the FDA to expand the application of quality management principles across two major laboratory centers. Current use of IQS software at the Center for Biological Evaluation and Research (CBER) is being expanded and a new initiative will be supported in the Center for Drug Evaluation and Research (CDER).
IQS has been tasked to support the adoption of ISO 17025 at the two research centers. This project will provide the information management systems that will help parts of the FDA comply with ISO 17025 standards. The quality practices will assist in the measurement, recording and reporting of product performance data developed from the testing of products developed for sale by drug and biologics companies.